Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart attack diagnosis revolution? new method could save lives

NCT ID NCT06570759

Diagnosis Sponsor: Başakşehir Çam & Sakura City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new way to classify heart attacks based on whether a coronary artery is fully blocked (occlusion) or not, instead of the traditional ST-elevation vs non-ST-elevation method. Researchers will compare outcomes in 6,000 patients to see if the new approach leads to better treatment decisions and fewer deaths or hospital readmissions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a more accurate way to diagnose and treat heart attacks, potentially saving lives and reducing hospital readmissions.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. The new method may not prove better than the current standard in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

6,000 people

The number who actually took part.

Started

Oct 2024

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria * Age \>18 years * ECG and/or clinical diagnosis of acute myocardial infarction Exclusion criteria * Active pregnancy or a suspicion of pregnancy * Rejection or withdrawal of consent * Failure to acquire any of the pre-participation ECGs * Non-ischemic myocardial injury * Application of thrombolytic therapy instead of primary PCI * Re-occlusion of the culprit lesion after intervention\* * New vessel occlusion during hospital stay\* * Exclusion from final analyses.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute coronary syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute coronary syndrome acute myocardial infarction disease myocardial infarction myocardial ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute coronary syndrome Diagnosis Morality Myocardial infarction Myocardial ischemia

Contacts and locations

Locations

  • Ankara Etlik City Hospital

    Ankara, 6010, Turkey (Türkiye)

  • Antalya City Hospital

    Antalya, 07080, Turkey (Türkiye)

  • Basaksehir Cam and Sakura City Hospital

    Istanbul, 3440, Turkey (Türkiye)

  • Bağcılar Training and Research Hospital

    Istanbul, Turkey (Türkiye)

  • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

    Istanbul, 34668, Turkey (Türkiye)

  • Erzurum Atatürk University Hospital

    Erzurum, 25040, Turkey (Türkiye)

  • Eskisehir Osmangazi University Hospital

    Eskişehir, 26040, Turkey (Türkiye)

  • Eskişehir City Hospital

    Eskişehir, 26080, Turkey (Türkiye)

  • Kartal Kosuyolu Training and Research Hospital

    Istanbul, 34865, Turkey (Türkiye)

  • Kutahya Health Sciences University

    Kütahya, 43020, Turkey (Türkiye)

  • Marmara University, Pendik Training and Research Hospital

    Istanbul, 34899, Turkey (Türkiye)

  • Mehmet Akif Ersoy Cardiovascular and Throacic Training and Research Hospital

    Istanbul, 34303, Turkey (Türkiye)

  • Mugla Sitki Kocman University

    Muğla, 48000, Turkey (Türkiye)

  • Necmettin Erbakan Meram Tıp Fakültesi Hastanesi

    Konya, 42080, Turkey (Türkiye)

  • Sirnak State Hospital

    Şırnak, 73000, Turkey (Türkiye)

  • Tokat Gaziosmanpaşa University

    Tokat Province, 60030, Turkey (Türkiye)

  • Van Training and Research Hospital

    Van, 65300, Turkey (Türkiye)

  • Yuzuncu Yil University Hospital

    Van, 65080, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.